Renaissance Capital logo

Frontier Acquisition Priced, Nasdaq: FRONU

Blank check company targeting the biotechnology sector (liquidated).

Industry: SPAC

Latest Trade: $10.15 +0.31 (+3.2%)

First Day Return: +1.3%

Return from IPO: -1.6%

Industry: SPAC

We are a newly incorporated blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not identified any potential business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. Our objective is to identify, acquire, and operate a business to generate attractive risk-adjusted returns for our shareholders by effecting a business combination with a target company that is rapidly growing and ready for public market ownership. While we may pursue an initial business combination opportunity in any business, industry, sector or geographic area, we intend to capitalize on the ability of our management team to identify promising opportunities at the intersection of the healthcare and technology industries, specifically within the biotechnology sector.
more less
IPO Data
IPO File Date 02/18/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 20.0
Deal Size ($mm) $200
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 03/10/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 20.0
Deal Size ($mm) $200
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Credit Suisse
Berenberg
Company Data
Headquarters New York, NY, United States
Founded 2021
Employees 4

Frontier Acquisition (FRONU) Performance